Загрузка...
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells
Indoleamine 2,3-dioxygenase 1 (IDO1), involved in the catabolism of tryptophan (Trp) to kynurenine (Kyn) is an important regulator of tumor-mediated immunosuppression implicated in resistance to anti-PD1 immunotherapy. We investigated the role of IDO1 in an anti-PD1-resistant lung cancer model (344S...
Сохранить в:
| Опубликовано в: : | Cancer Lett |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6027590/ https://ncbi.nlm.nih.gov/pubmed/29746927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.05.005 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|